James Woodmansee
Family Medicine · Provo, UTNPI 1093703530
Payments from drug & device makers
Across 413 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$495
- Novo Nordisk$435
- Boehringer Ingelheim$410
- Pfizer$401
- Lilly USA, LLC$351
- plus $3K from 44 others
What the payments were for
- Food & beverage$6,315100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Confirm Rx$113
How this compares
$6,319 in reported general payments places this provider in the 85th percentile of 928 family medicine providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SprixKetorolac Tromethamine | 12 | $125,242 |
| EliquisApixaban | 50 | $31,523 |
| MounjaroTirzepatide | 20 | $21,252 |
| RoxicodoneOxycodone Hcl | 13 | $16,298 |
| MyrbetriqMirabegron | 20 | $10,988 |
| JardianceEmpagliflozin | 15 | $10,489 |
| Emgality SyringeGalcanezumab-Gnlm | 11 | $7,542 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $6,784 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 91 | $2,744 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $2,007 |
| Estradiol (Twice Weekly)Estradiol | 25 | $1,892 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $1,414 |
| Zolpidem Tartrate | 125 | $1,354 |
| Fentanyl | 14 | $1,141 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $933 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $401 | $31,52350 claims |
| Lilly USA, LLCMounjaro | $351 | $21,25220 claims |
| Astellas Pharma US IncMyrbetriq | $495 | $10,98820 claims |
| Boehringer IngelheimJardiance | $410 | $10,48915 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $55857 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 928 family medicine providers in Utah.
Other family medicine in Provo
- David FlindersProvo$498K
- Ronald BrowneProvo$487K
- Steven BloinkProvo$17K
- John TemplemanProvo$17K
- Heather HarrisonProvo$14K
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.